(Q40518557)

English

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants

scientific article published on October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants (English)

1 reference

Europe PubMed Central

21 September 2017

0 references

object named as

Larisa Rudenko

14

0 references

object named as

Irina Kiseleva

2

0 references

author name string

Thomas Palker

1

1 reference

Europe PubMed Central

21 September 2017

Kimberly Johnston

3

1 reference

Europe PubMed Central

21 September 2017

Qin Su

4

1 reference

Europe PubMed Central

21 September 2017

Timothy Toner

5

1 reference

Europe PubMed Central

21 September 2017

Christopher Szymkowiak

6

1 reference

Europe PubMed Central

21 September 2017

Wan-Sang Kwan

7

1 reference

Europe PubMed Central

21 September 2017

Boris Rubin

8

1 reference

Europe PubMed Central

21 September 2017

Luba Petrukhin

9

1 reference

Europe PubMed Central

21 September 2017

Joan Wlochowski

10

1 reference

Europe PubMed Central

21 September 2017

Juanita Monteiro

11

1 reference

Europe PubMed Central

21 September 2017

Nikolai Kraiouchkine

12

1 reference

Europe PubMed Central

21 September 2017

Daniel DiStefano

13

1 reference

Europe PubMed Central

21 September 2017

Alan Shaw

15

1 reference

Europe PubMed Central

21 September 2017

Rima Youil

16

1 reference

Europe PubMed Central

21 September 2017

publication date

1 October 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

105

1 reference

Europe PubMed Central

21 September 2017

183-194

1 reference

Europe PubMed Central

21 September 2017

2

1 reference

Europe PubMed Central

21 September 2017

Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Influenza Immunization for Children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Emerging infections: pandemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Host cell-mediated variation in H3N2 influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Novel generations of influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Adaptation and Growth Characteristics of Influenza Virus at 25° C

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

An evaluation of the genetic stability and pathogenicity of the Russian cold-adapted influenza A donor strains A/Leningrad/134/17/57 and A/Leningrad/134/47/57 in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Molecular mapping of influenza virus RNA polymerase by site-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Gene analysis of reassortant influenza virus by RT-PCR followed by restriction enzyme digestion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Evidence for host-cell selection of influenza virus antigenic variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

The impact of influenza epidemics on mortality: introducing a severity index.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

The impact of influenza epidemics on hospitalizations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Preparation and characterisation of attenuated cold-adapted influenza A reassortants derived from the A/Leningrad/134/17/57 donor strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

The antigenic structure of a human influenza A (H1N1) virus isolate grown exclusively in MDCK cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.009

7 January 2021

Identifiers

10.1016/J.VIRUSRES.2004.05.009

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40518557&oldid=1899832417"